Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

April 01, 1995; Volume 273,Issue 1
  • You have access
    Dilatation of the basilar artery in response to selective activation of endothelin B receptors in vivo.
    T Kitazono, D D Heistad and F M Faraci
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 1-6;
  • You have access
    Differential effects of direct and indirect dopamine agonists on the induction of gnawing in C57Bl/6J mice.
    E Tirelli and J M Witkin
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 7-15;
  • You have access
    Secretion of cyclic GMP by cultured epithelial and fibroblast cell lines in response to nitric oxide.
    M J Patel, D M Wypij, D A Rose, T J Rimele and J S Wiseman
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 16-25;
  • You have access
    Functional expression of transporter for beta-lactam antibiotics and dipeptides in Xenopus laevis oocytes injected with messenger RNA from human, rat and rabbit small intestines.
    I Tamai, N Tomizawa, T Takeuchi, K Nakayama, H Higashida and A Tsuji
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 26-31;
  • You have access
    Tetrandrine, a Ca++ antagonist: effects and mechanisms of action in vascular smooth muscle cells.
    Q Y Liu, B Li, J M Gang, E Karpinski and P K Pang
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 32-39;
  • You have access
    Differential effects of dopamine D1 and D2 receptor agonists on schedule-controlled behavior of squirrel monkeys.
    J Bergman, S Rosenzweig-Lipson and R D Spealman
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 40-48;
  • You have access
    Comparison of the effects of evening primrose oil and triglycerides containing gamma-linolenic acid on nerve conduction and blood flow in diabetic rats.
    K C Dines, N E Cameron and M A Cotter
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 49-55;
  • You have access
    Renal vascular and tubular actions of calcitonin gene-related peptide: effect of NG-nitro-L-arginine methyl ester.
    A M Elhawary and C C Pang
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 56-63;
  • You have access
    Carvedilol, a new beta-adrenoreceptor blocker, vasodilator and free-radical scavenger, exerts an anti-shock and endothelial protective effect in rat splanchnic ischemia and reperfusion.
    T A Christopher, B L Lopez, T L Yue, G Z Feuerstein, R R Ruffolo and X L Ma
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 64-71;
  • You have access
    Site-selective effect of bicarbonate on amantadine renal transport: quinine-sensitive in proximal vs quinidine-sensitive sites in distal tubules.
    M R Escobar and D S Sitar
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 72-79;
  • You have access
    Heparin attenuates the effect of mitogenic vasoconstrictors on mesangial cell proliferation and handling of immunoglobulin G complexes.
    J Mattana and P C Singhal
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 80-87;
  • You have access
    Enantioselective disposition of ibuprofen in elderly persons with and without renal impairment.
    A C Rudy, P M Knight, D C Brater and S D Hall
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 88-93;
  • You have access
    Dissociation of tissue thiols content from nitroglycerin-induced cyclic-3',5'-guanosine monophosphate and the state of tolerance: in vivo experiments in rats.
    A I Haj-Yehia and L Z Benet
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 94-100;
  • You have access
    (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    R Schreiber, M Brocco, V Audinot, A Gobert, S Veiga and M J Millan
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 101-112;
  • You have access
    In vitro and in vivo testing of hydralazine genotoxicity.
    A Martelli, A Allavena, G B Campart, R Canonero, M Ghia, F Mattioli, E Mereto, L Robbiano and G Brambilla
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 113-120;
  • You have access
    Pharmacokinetic interaction between isradipine and lovastatin in normal, female and male volunteers.
    L X Zhou, D K Finley, A E Hassell and J L Holtzman
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 121-127;
  • You have access
    Involvement of monoamine uptake inhibition and local anesthesia in the cardiovascular response to cocaine in conscious rabbits.
    B Szabo, A Obergfell and K Starke
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 128-137;
  • You have access
    Pharmacological analysis of the scratching produced by dopamine D2 agonists in squirrel monkeys.
    R Pellón, P Flores, K Alling, J M Witkin and J L Katz
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 138-145;
  • You have access
    Organic anion transport in rabbit renal basolateral membrane vesicles.
    M J Makhuli, C A Polkowski and S M Grassl
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 146-153;
  • You have access
    Relative potency and arteriovenous selectivity of nitrovasodilators on human blood vessels: an insight into the targeting of nitric oxide delivery.
    R J MacAllister, A L Calver, J Riezebos, J Collier and P Vallance
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 154-160;
  • You have access
    Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors.
    I Gozes, G Lilling, R Glazer, A Ticher, I E Ashkenazi, A Davidson, S Rubinraut, M Fridkin and D E Brenneman
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 161-167;
  • You have access
    Cardiac electrophysiologic and antiarrhythmic actions of tedisamil.
    A A Wallace, R F Stupienski, E P Baskin, S D Appleby, T Kothstein, J R Gehret, S W King, D C Remy and J J Lynch
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 168-175;
  • You have access
    The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
    H J Showell, E R Pettipher, J B Cheng, R Breslow, M J Conklyn, C A Farrell, G P Hingorani, E D Salter, B C Hackman and D J Wimberly
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 176-184;
  • You have access
    Brain and plasma levels of opioid peptides are altered in rats with thioacetamide-induced fulminant hepatic failure: implications for the treatment of hepatic encephalopathy with opioid antagonists.
    C Yurdaydin, Y Li, J H Ha, E A Jones, R Rothman and A S Basile
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 185-192;
  • You have access
    Activated recombinant human protein C does not attenuate recruitment of neutrophils in rat models of acute inflammation.
    E C O'Leary, J A Schelm and P J Simpson
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 193-198;
  • You have access
    Central kappa opioids blunt the renal excretory responses to volume expansion by a renal nerve-dependent mechanism.
    D R Kapusta and J C Obih
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 199-205;
  • You have access
    Verapamil attenuates calcium-induced mitochondrial swelling and respiratory dysfunction.
    W S Koo, P E Gengaro, T J Burke and R W Schrier
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 206-212;
  • You have access
    Studies of the biogenic amine transporters. V. Demonstration of two binding sites for the cocaine analog [125I]RTI-55 associated with the 5-HT transporter in rat brain membranes.
    M L Silverthorn, C M Dersch, M H Baumann, J L Cadet, J S Partilla, K C Rice, F I Carroll, K M Becketts, A Brockington and R B Rothman
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 213-222;
  • You have access
    Gramicidin as a potential immunosuppressant for organ transplantation: suppression of human lymphocyte blastogenesis in vitro and prolongation of heart allograft survival in the rat.
    T Hirano, K Oka and T Tamaki
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 223-229;
  • You have access
    Coadministration of cholinesterase inhibitors and idazoxan: effects of neurotransmitters in rat cortex in vivo.
    G Cuadra and E Giacobini
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 230-240;
  • You have access
    Modulation of basal and stress-induced release of acetylcholine and dopamine in rat brain by abecarnil and imidazenil, two anxioselective gamma-aminobutyric acidA receptor modulators.
    L Dazzi, C Motzo, A Imperato, M Serra, G L Gessa and G Biggio
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 241-247;
  • You have access
    Differential blockade of voltage-sensitive calcium channels at the mouse neuromuscular junction by novel omega-conopeptides and omega-agatoxin-IVA.
    S S Bowersox, G P Miljanich, Y Sugiura, C Li, L Nadasdi, B B Hoffman, J Ramachandran and C P Ko
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 248-256;
  • You have access
    Hydroxocobalamin (vitamin B12a) prevents and reverses endotoxin-induced hypotension and mortality in rodents: role of nitric oxide.
    S S Greenberg, J Xie, J M Zatarain, D R Kapusta and M J Miller
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 257-265;
  • You have access
    Oral administration of clotrimazole and blockade of human erythrocyte Ca(++)-activated K+ channel: the imidazole ring is not required for inhibitory activity.
    C Brugnara, C C Armsby, M Sakamoto, N Rifai, S L Alper and O Platt
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 266-272;
  • You have access
    Identification of the primary muscarinic autoreceptor subtype in rat striatum as m2 through a correlation of in vivo microdialysis and in vitro receptor binding data.
    W Billard, H Binch, G Crosby and R D McQuade
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 273-279;
  • You have access
    Effects and interactions of gentamicin, polyaspartic acid and diuretics on urine calcium concentration.
    W C Elliott and D S Patchin
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 280-284;
  • You have access
    Radioligand binding analysis of receptor subtypes in two FP receptor preparations that exhibit different functional rank orders of potency in response to prostaglandins.
    D F Woodward, C E Fairbairn, A H Krauss, R A Lawrence and C E Protzman
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 285-287;
  • You have access
    Dynorphin A modulates acute and chronic opioid effects.
    L P Hooke, L He and N M Lee
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 292-297;
  • You have access
    The effect of verapamil on the transport of peptides across the blood-brain barrier in rats: kinetic evidence for an apically polarized efflux mechanism.
    E G Chikhale, P S Burton and R T Borchardt
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 298-303;
  • You have access
    Melatonin agonists modulate 5-HT2A receptor-mediated neurotransmission: behavioral and biochemical studies in the rat.
    A S Eison, R P Freeman, V B Guss, U L Mullins and R N Wright
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 304-308;
  • You have access
    Combination treatment of the partial D2 agonist terguride with the D1 agonist SKF 82958 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.
    T Akai, M Ozawa, M Yamaguchi, E Mizuta and S Kuno
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 309-314;
  • You have access
    The discordant influences of infarct healing on the electrophysiologic effects of procainamide and N-acetylprocainamide.
    S D Nelson, K S Coyne and J Meimer
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 315-319;
  • You have access
    Adenosine receptor activation modulates intraocular pressure in rabbits.
    C E Crosson
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 320-326;
  • You have access
    Behavioral and neurochemical effects of opioids in the paramedian midbrain tegmentum including the median raphe nucleus and ventral tegmental area.
    M A Klitenick and D Wirtshafter
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 327-336;
  • You have access
    Regulation of jejunal arterioles by capsaicin-sensitive nerves in Nippostrongylus brasiliensis-sensitized rats.
    R Mathison and J S Davison
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 337-343;
  • You have access
    Bradykinin acting on B2 receptors contracts colon circular muscle cells by IP3 generation and adenylate cyclase inhibition.
    W L Hasler, S Kurosawa, T Takahashi, H Feng, T S Gaginella and C Owyang
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 344-350;
  • You have access
    Intravenous caffeine in stimulant drug abusers: subjective reports and physiological effects.
    C R Rush, J T Sullivan and R R Griffiths
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 351-358;
  • You have access
    SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist.
    E J Bilsky, S N Calderon, T Wang, R N Bernstein, P Davis, V J Hruby, R W McNutt, R B Rothman, K C Rice and F Porreca
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 359-366;
  • You have access
    Structural determinants of the melanocortin peptides required for activation of melanocortin-3 and melanocortin-4 receptors.
    H Miwa, I Gantz, Y Konda, Y Shimoto and T Yamada
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 367-372;
  • You have access
    Low endogenous dopamine function in brain predisposes to high alcohol preference and consumption: reversal by increasing synaptic dopamine.
    S R George, T Fan, G Y Ng, S Y Jung, B F O'Dowd and C A Naranjo
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 373-379;
  • You have access
    Adrenergic modulation of a spinal sympathetic reflex in the rat.
    S F Morrison and Y Z Ge
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 380-385;
  • You have access
    Adverse effects of paternal opiate exposure on offspring development and sensitivity to morphine-induced analgesia.
    T J Cicero, B Nock, L O'Connor, M Adams and E R Meyer
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 386-392;
  • You have access
    The effect of chemical substitution on the metabolic activation, metabolic detoxication, and pharmacological activity of amodiaquine in the mouse.
    J E Ruscoe, H Jewell, J L Maggs, P M O'Neill, R C Storr, S A Ward and B K Park
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 393-404;
  • You have access
    Pharmacokinetic-pharmacodynamic modelling of the cardiovascular effects of R- and S-N6-phenylisopropyladenosine in conscious normotensive rats.
    R A Mathôt, B C Van den Aarsen, W Soudijn, D D Breimer, A P Ijzerman and M Danhof
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 405-414;
  • You have access
    Role of presynaptic input in the ontogeny of adrenergic cell signaling in rat brain: beta receptors, adenylate cyclase and c-fos protooncogene expression.
    J P Wagner, F J Seidler, S E Lappi, E C McCook and T A Slotkin
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 415-426;
  • You have access
    Pretranslational down regulation of cytochrome P450 2C11 in vitamin A-deficient male rat liver: prevention by dietary inclusion of retinoic acid.
    R Martini, A M Butler, X M Jiang and M Murray
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 427-434;
  • You have access
    [3H]WIN 35,428 binding in the caudate nucleus of the rabbit: evidence for a single site on the dopamine transporter.
    V J Aloyo, J S Ruffin, P S Pazdalski, A L Kirifides and J A Harvey
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 435-444;
  • You have access
    Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system.
    F J White, X T Hu, X F Zhang and M E Wolf
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 445-454;
  • You have access
    High-dose vitamin E supplementation has no effect on ethanol-induced pathological liver injury.
    S M Sadrzadeh, M Meydani, U Khettry and A A Nanji
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 455-460;
  • You have access
    Autoradiographic localization and characterization of [3H]alpha-trinositol (1D-myo-inositol 1,2,6-trisphosphate) binding sites in human and mammalian tissues.
    D A Walsh, P I Mapp, J M Polak and D R Blake
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 461-469;
  • You have access
    Muscarinic regulation of the cardiac CFTR Cl- current by quaternary ammonium compounds.
    S I Zakharov, R A Wagner and R D Harvey
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 470-481;
  • You have access
    Agonist-independent, muscle-type-specific signal transduction pathways in cat esophageal and lower esophageal sphincter circular smooth muscle.
    U D Sohn, B Han, A H Tashjian, J Behar and P Biancani
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 482-491;
  • You have access
    Prenatal exposure to cocaine selectively reduces D1 dopamine receptor-mediated activation of striatal Gs proteins.
    H Y Wang, S Runyan, E Yadin and E Friedman
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 492-498;
  • You have access
    Serotonin and thyrotropin-releasing hormone do not augment their effects on gastric motility on their microinjection into the nucleus raphe obscurus of the rat.
    Z K Krowicki and P J Hornby
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 499-508;
  • You have access
    Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
    S Kim, K Ohta, A Hamaguchi, T Omura, T Yukimura, K Miura, Y Inada, Y Ishimura, F Chatani and H Iwao
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 509-515;
  • You have access
    Partial and full dopamine D1 agonists produce comparable increases in ventral pallidal neuronal activity: contribution of endogenous dopamine.
    B A Heidenreich, R B Mailman, D E Nichols and T C Napier
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 516-525;
  • You have access
    Effect of zolpidem on gamma-aminobutyric acid (GABA)-induced inhibition predicts the interaction of ethanol with GABA on individual neurons in several rat brain regions.
    H E Criswell, P E Simson, D J Knapp, L L Devaud, T J McCown, G E Duncan, A L Morrow and G R Breese
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 526-536;
  • You have access
    Characterization of the adenosine A1 receptor-activated potassium current in rat locus ceruleus neurons.
    W J Pan, S S Osmanović and S A Shefner
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 537-544;
  • You have access
    Differential toxicity of the protein phosphatase inhibitors microcystin and calyculin A.
    M T Runnegar, T Maddatu, L D Deleve, N Berndt and S Govindarajan
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 545-553;
  • You have access
    Sodium channel blockers reduce oxygen-glucose deprivation-induced cortical neuronal injury when combined with glutamate receptor antagonists.
    J J Lynch, S P Yu, L M Canzoniero, S L Sensi and D W Choi
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 554-560;
  • You have access
    Pulmonary CYP2E1 bioactivates 1,1-dichloroethylene in male and female mice.
    R P Lee and P G Forkert
    Journal of Pharmacology and Experimental Therapeutics April 1995, 273 (1) 561-567;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 273, Issue 1
1 Apr 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • KBP-042 as Adjunct Therapy to Metformin
  • SARS-CoV-2 Drug Discovery
  • Nose-to-Brain Delivery
  • Interaction between Bupropion and MDMA
  • Smoking Could Worsen COVID-19 Outcome
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics